Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer (IBIS II)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Jill Knox, Queen Mary University of London
ClinicalTrials.gov Identifier:
NCT00078832
First received: March 8, 2004
Last updated: April 13, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2022
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)